Valute / CERO
CERO: CERo Therapeutics Holdings Inc
8.57
USD
0.07
(0.81%)
Il tasso di cambio CERO ha avuto una variazione del -0.81% per oggi. Durante la giornata, lo strumento è stato scambiato ad un minimo di 8.56 e ad un massimo di 8.64.
Segui le dinamiche di CERo Therapeutics Holdings Inc. Le quotazioni in tempo reale aiutano a reagire velocemente alle variazioni di mercato. Scorrendo tra i diversi timeframe, è possibile monitorare le tendenze e le dinamiche dei tassi di cambio di minuti, ore, giorni, settimane e mesi. Utilizza queste informazioni per prevedere i cambiamenti del mercato e prendere decisioni di trading consapevoli.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
CERO News
- Investing Cero Therapeutics regains Nasdaq compliance after bid price deficiency
- Investing Cero Therapeutics adds institutional investors in Series D preferred stock sale
- Investing Cero Therapeutics stock rating upgraded to Buy on solid tumor approach
- Investing U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.10%
- Benzinga Dow Surges 150 Points; Korn Ferry Earnings Top Views - CERo Therapeutics Hldgs (NASDAQ:CERO), Aptevo Therapeutics (NASDAQ:APVO)
- Benzinga Aurora Cannabis, Bitdeer Technologies Group And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Aurora Cannabis (NASDAQ:ACB), Bitdeer Technologies (NASDAQ:BTDR)
- Benzinga Why Beyond Air Shares Are Trading Lower By Over 23%; Here Are 20 Stocks Moving Premarket - Acurx Pharmaceuticals (NASDAQ:ACXP), Biomea Fusion (NASDAQ:BMEA)
- Investing U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.70%
- Investing CERo Therapeutics stock soars after FDA grants Orphan Drug Designation
- Benzinga Crude Oil Rises Sharply; Jabil Earnings Top Views - CERo Therapeutics Hldgs (NASDAQ:CERO), Acurx Pharmaceuticals (NASDAQ:ACXP)
- Benzinga US Stocks Lower; Retail Sales Decline In May - CERo Therapeutics Hldgs (NASDAQ:CERO), Acurx Pharmaceuticals (NASDAQ:ACXP)
- Benzinga What's Going On With Cero Therapeutics Stock Tuesday? - CERo Therapeutics Hldgs (NASDAQ:CERO)
- Investing FDA grants orphan drug status to CERo’s leukemia treatment
- Investing U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.79%
- Investing CERo Therapeutics to implement 1-for-20 reverse stock split
- TipRanks Upcoming Stock Splits This Week (June 9 to June 13) – Stay Invested - TipRanks.com
- Investing CERo Therapeutics issues additional Series D stock
- Investing CERo Therapeutics Holdings, Inc. Announces Continued Enhancement of Intellectual Property Portfolio with Two Granted U.S. Patents and European Patent Application Allowance Regarding Company’s Lead
- Investing CERO stock plunges to 52-week low at $0.47 amid market challenges
- Investing CERo Therapeutics begins phase 1 trial for leukemia treatment
- Investing CERO stock plunges to 52-week low of $0.53 amid market challenges
- Investing Maxim Group sets Cero Therapeutics stock with $3 target
- Benzinga Gold Gains 1%; Bristol Myers Squibb Posts Upbeat Results - ASGN (NYSE:ASGN), Bristol-Myers Squibb (NYSE:BMY)
- Benzinga Dow Jumps Over 200 Points; PepsiCo Cuts Earnings Outlook - CERo Therapeutics Hldgs (NASDAQ:CERO), Cantor Equity Partners (NASDAQ:CEP)
Intervallo Giornaliero
8.56
8.64
Intervallo Annuale
0.04
26.99
- Chiusura Precedente
- 8.92
- Apertura
- 8.64
- Bid
- 8.57
- Ask
- 8.87
- Minimo
- 8.56
- Massimo
- 8.64
- Volume
- 16
- Variazione giornaliera
- -0.81%
- Variazione Mensile
- -7.95%
- Variazione Semestrale
- 316.02%
- Variazione Annuale
- 5256.25%
08 luglio, martedì
15:30
USD
- Agire
- 3.925%
- Fcst
- Prev
- 3.940%
16:00
USD
- Agire
- Fcst
- Prev
16:00
USD
- Agire
- 98.6
- Fcst
- 102.8
- Prev
- 98.8
17:00
USD
- Agire
- 3.891%
- Fcst
- Prev
- 3.972%
19:00
USD
- Agire
- Fcst
- $13.27 B
- Prev
- $17.87 B